Ariosa Asks USPTO to Nix Sequenom Prenatal Test Patent

Ariosa Diagnostics Inc. filed a petition for inter partes review Monday asking the U.S. Patent and Trademark Office to invalidate a prenatal blood test patent that Sequenom Inc. accuses Ariosa of infringing.
Law360